These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20047059)

  • 1. Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer's disease.
    Ringman JM; Pope W; Salamon N
    J Neurol; 2010 May; 257(5):839-42. PubMed ID: 20047059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.
    Lee GJ; Lu PH; Medina LD; Rodriguez-Agudelo Y; Melchor S; Coppola G; Braskie MN; Hua X; Apostolova LG; Leow AD; Thompson PM; Ringman JM
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):154-62. PubMed ID: 23085935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.
    Scahill RI; Ridgway GR; Bartlett JW; Barnes J; Ryan NS; Mead S; Beck J; Clarkson MJ; Crutch SJ; Schott JM; Ourselin S; Warren JD; Hardy J; Rossor MN; Fox NC
    J Alzheimers Dis; 2013; 35(1):199-212. PubMed ID: 23380992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease.
    Ringman JM; Medina LD; Rodriguez-Agudelo Y; Chavez M; Lu P; Cummings JL
    Curr Alzheimer Res; 2009 Aug; 6(4):341-6. PubMed ID: 19689233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation.
    Fox NC; Warrington EK; Stevens JM; Rossor MN
    Ann N Y Acad Sci; 1996 Jan; 777():226-32. PubMed ID: 8624089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.
    Apostolova LG; Hwang KS; Medina LD; Green AE; Braskie MN; Dutton RA; Lai J; Geschwind DH; Cummings JL; Thompson PM; Ringman JM
    Dement Geriatr Cogn Disord; 2011; 32(2):118-25. PubMed ID: 21952501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter hyperintensities and patterns of atrophy in early onset Alzheimer's disease with causative gene mutations.
    Mao C; Li J; Huang X; Dong L; Liu C; Peng B; Cui L; Gao J
    Clin Neurol Neurosurg; 2021 Apr; 203():106552. PubMed ID: 33601235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing familial corticobasal syndrome due to Alzheimer's disease pathology and PSEN1 mutations.
    Lam B; Khan A; Keith J; Rogaeva E; Bilbao J; St George-Hyslop P; Ghani M; Freedman M; Stuss DT; Chow T; Black SE; Masellis M
    Alzheimers Dement; 2017 May; 13(5):520-530. PubMed ID: 27743520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
    Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.
    Quiroz YT; Stern CE; Reiman EM; Brickhouse M; Ruiz A; Sperling RA; Lopera F; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):556-61. PubMed ID: 23134660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.
    Braskie MN; Medina LD; Rodriguez-Agudelo Y; Geschwind DH; Macias-Islas MA; Thompson PM; Cummings JL; Bookheimer SY; Ringman JM
    Hum Brain Mapp; 2013 Dec; 34(12):3308-19. PubMed ID: 22806961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.
    Fox NC; Warrington EK; Freeborough PA; Hartikainen P; Kennedy AM; Stevens JM; Rossor MN
    Brain; 1996 Dec; 119 ( Pt 6)():2001-7. PubMed ID: 9010004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New visual rating system for medial temporal lobe atrophy: a simple diagnostic tool for routine examinations.
    Kaneko T; Kaneko K; Matsushita M; Kadoya M; Ihara N; Ryokawa A; Ogihara T; Inuzuka S; Ueda H
    Psychogeriatrics; 2012 Jun; 12(2):88-92. PubMed ID: 22712641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
    Chetelat G; Baron JC
    Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family.
    Gallo M; Frangipane F; Cupidi C; De Bartolo M; Turone S; Ferrari C; Nacmias B; Grimaldi G; Laganà V; Colao R; Bernardi L; Anfossi M; Conidi ME; Vasso F; Curcio SAM; Mirabelli M; Smirne N; Torchia G; Muraca MG; Puccio G; Di Lorenzo R; Piccininni M; Tedde A; Maletta RG; Sorbi S; Bruni AC
    Neurobiol Aging; 2017 Aug; 56():213.e7-213.e12. PubMed ID: 28532646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers.
    Petok JR; Myers CE; Pa J; Hobel Z; Wharton DM; Medina LD; Casado M; Coppola G; Gluck MA; Ringman JM
    Neurobiol Aging; 2018 May; 65():149-157. PubMed ID: 29494861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
    Zhang C; Browne A; Kim DY; Tanzi RE
    Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease.
    Quan M; Zhao T; Tang Y; Luo P; Wang W; Qin Q; Li T; Wang Q; Fang J; Jia J
    Alzheimers Res Ther; 2020 Jan; 12(1):14. PubMed ID: 31937364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.